Cardiovascular Management in Family Medicine

download Cardiovascular Management in Family Medicine

of 43

description

Cardiovascular Management in Family Medicine

Transcript of Cardiovascular Management in Family Medicine

  • 7/18/2019 Cardiovascular Management in Family Medicine

    1/43

    CardiovascularManagement in Family

    MedicineErwin Sukandi

    Cardiology Division

    Internal Medicine Department

    FAMUS/RSM !alem"ang

  • 7/18/2019 Cardiovascular Management in Family Medicine

    2/43

    Introduction

    Cardiovascular disease is a ma#or cause o$ mor"idityand mortality in our society%

    &'e $amily p'ysician s'ould "e pro(cient in t'ediagnosis and management o$ a variety o$

    cardiovascular disorders% Family p'ysicians provide compre'ensive and

    continuing care to individuals and $amilies) wit'particular attention to "e'avioral and li$estyle

    $actors% At times t'e $amily p'ysician may (nd it appropriate

    to seek consultation $rom a cardiologist to eit'ermanage or co*manage a patient $or optimal care%

  • 7/18/2019 Cardiovascular Management in Family Medicine

    3/43

    Competencies

    Understand "asic and clinical knowledge o$ cardiacanatomy and pat'op'ysiology o$ commoncardiovascular diseases% +Medical ,nowledge-

    !er$orm an appropriate cardiac 'istory and p'ysical

    e.amination) document (ndings) develop anappropriate dierential diagnosis) and plan $or

    $urt'er evaluation and management% +!atient Care)Medical ,nowledge) Interpersonal and

    Communication Skills- Use evidence "ased knowledge regarding primary

    and secondary prevention o$ cardiovascular disease%+Medical ,nowledge) !atient Care-

  • 7/18/2019 Cardiovascular Management in Family Medicine

    4/43

    Competencies

    Review current practices regarding t'e care o$patients wit' cardiovascular disease and developplans to improve t'e care% +!atient Care) Medical,nowledge) !ractice*"ased 0earning andImprovement) !ro$essionalism-

    1ork wit' p'ysicians) nurses) p'armacists)dieticians) and ot'er 'ealt' care pro$essionals w'o

    care $or patients wit' common cardiovasculardiseases% +!atient Care) Medical ,nowledge)!ro$essionalism) Systems*"ased !ractice-

  • 7/18/2019 Cardiovascular Management in Family Medicine

    5/43

    Attitudes

    2 &'e importance o$ p'ysician and patient working as partnersto promote optimal cardiovascular 'ealt'%

    2 A compassionate approac' to t'e care o$ patients wit' cardiacdisease%

    2 &'e psyc'osocial and economic impact o$ cardiovasculardisease on t'e individual and $amily and use o$ t'e 'ealt' caresystem to assist as needed%

    2 Support o$ t'e individual and $amily t'roug' consultation)evaluation) treatment) and re'a"ilitation%

    2 &'e importance o$ li$estyle $actors on t'e development ande.acer"ation o$ cardiovascular disease%

    2 A multidisciplinary approac' to t'e care o$ individuals wit'cardiovascular disease%

  • 7/18/2019 Cardiovascular Management in Family Medicine

    6/43

    ,nowledge3% 4ormal cardiovascular anatomy and p'ysiology

    5% C'anges in cardiovascular p'ysiology wit' ageand pregnancy

    6% Risk $actors o$ CAD

    i% yperlipidemia

    ii% Cigarette smokingiii% 7enetic predisposition

    iv% Sedentary li$e style

    v% ypertension

    vi% Dia"etes mellitusvii% 8"esity

    viii%4utrition

    i.% ormonal status

    .% Emotional stress

  • 7/18/2019 Cardiovascular Management in Family Medicine

    7/43

    ,nowledge9% Cardiovascular 'istory

    :% Cardiovascular p'ysical e.amination;% 4oninvasive e.aminationsa% Electrocardiograp'y

    "% C'est radiograp'y

    c% Stress testing) including treadmill/"icycle or

    p'armacologic tec'nied tomograp'y +C&-

    i% Magnetic resonance imaging +MRI- and Magneticresonance angiogram +MRA-

  • 7/18/2019 Cardiovascular Management in Family Medicine

    8/43

    ?% Invasive e.aminations

    a% Diagnostic cardiac cat'eteri>ation andangiograp'y

    "% Diagnostic carotid and perip'eral vascularangiograp'y

    c% Intracoronary and perip'eral vascularintervention using appropriate devices

    d% Internal monitoring devices

    i% Central venous and perip'eral arterialcat'eter

    e% Electrop'ysiologic studies

    $% Indications and contraindications o$ t'erapeuticinterventions

    i% Coronary artery "ypass

    ii% Angioplasty tec'ni

  • 7/18/2019 Cardiovascular Management in Family Medicine

    9/43

    ,nowledge

    @% Relevant la"oratory interpretation) including

    serum en>ymes) isoen>ymes) lipids) and "*typenatriuretic peptide +4!- or pro*4!%

    B% Speci(c diseases/conditionsa% Coronary artery disease

    i% Sta"le/unsta"le anginaii% Myocardial in$arction) wit' and wit'out

    complications3- Cardiogenic s'ock5- Dysr'yt'mias6- !apillary muscle dys$unction and rupture9- =entricular rupture:- Aneurysm

    iii% Sudden deat'

    "% Syncope) cardiogenic and non*cardiogenic

  • 7/18/2019 Cardiovascular Management in Family Medicine

    10/43

    ,nowledge

    c% Dysr'yt'miasi% &ac'yarr'yt'mia

    3- Supraventricular

    5- =entricular

    6- Reentrant

    ii% radyarr'yt'miaiii% Ectopy

    3- Atrial

    5- =entricular

    d% ypertensioni% Essential

    ii% Secondary

    iii% !ulmonary

  • 7/18/2019 Cardiovascular Management in Family Medicine

    11/43

    ,nowledge

    e% !ulmonary 'eart disease

    i% Cor pulmonale

    $% eart $ailure

    i% Systolic dys$unction

    ii% Diastolic dys$unction

    g% =enous &'rom"oem"olic disease +=&E-

    '% =alvular 'eart disease

    i% R'eumaticii% Congenital

    iii% Degenerative

    iv% Mitral valve prolapse syndrome

  • 7/18/2019 Cardiovascular Management in Family Medicine

    12/43

    i% Congenital 'eart diseasei% Common le$t to rig't s'unts +acyanotic-

    ii% Common rig't to le$t s'unts +cyanotic-iii% Common o"structive pro"lems

    #% Dissecting aneurysmk% Innocent 'eart murmurs

    l% !erip'eral vascular diseasei% Aneurysmii% Carotid at'erosclerosisiii% Arterial diseaseiv% Arteriosclerosis o"literans

    m% Cardiomyopat'iesi% Congestive +dilated-ii% Restrictiveiii% ypertrop'ic cardiomyopat'yiv% !ostpartum

  • 7/18/2019 Cardiovascular Management in Family Medicine

    13/43

    n% !ericardial diseaseo% In$ection*related

    i% =iral myocarditisii% Su"acute "acterial endocarditisiii% ,awasakis disease

    p% 8t'er cardiac disordersi% Immunologic

    3- Acute r'eumatic $ever5- Autoimmune disorders

    ii% !syc'ogeniciii% &raumaticiv% 4utritional

    v% My.omavi% &'yroid dys$unctionvii% Mar$an syndromeviii%Drug*related suc' as cocaine) steroids and

    c'emot'erapeutic agents

  • 7/18/2019 Cardiovascular Management in Family Medicine

    14/43

    ,nowledge

  • 7/18/2019 Cardiovascular Management in Family Medicine

    15/43

    Skills

    In t'e appropriate setting) t'e resident s'oulddemonstrate t'e a"ility to per$orm orappropriately re$er

    3% Diagnostic proceduresa% !er$ormance o$ 'istory taking and p'ysical

    e.amination

    "% Mec'anics and interpretation o$ EC7

    c% Interpretation o$ c'est radiograp'sd% &readmill/"icycle stress test monitoring and

    interpretation

    e% Am"ulatory EC7 monitoring and interpretation

  • 7/18/2019 Cardiovascular Management in Family Medicine

    16/43

    Skills

    5% &'erapeutic procedures

    a% Risk management

    "% Cardiopulmonary resuscitation +C!R-) "ot' "asic li$esupport +0S- and advanced cardiac li$e support +AC0S-

    c% &reating dysr'yt'mias and conduction distur"ances

    d% Use o$ e.ternal temporary pacemakers

    e% Management o$ acute myocardial in$arction)

    postin$arction care) and complications$% Congestive 'eart $ailure

    g% ypertensive emergencies

  • 7/18/2019 Cardiovascular Management in Family Medicine

    17/43

    '% Supervision and management o$ cardiovascularre'a"ilitation

    i% !syc'osocial issues

    i% Se.ual $unctioningii% Depression

    iii% Family dynamics

    #% Management o$ patients a$ter an intervention

    i% 0i$estyle ad#ustments

    ii% Coronary artery "ypass surgery

    iii% =alve surgery

    iv% Congenital 'eart disease surgery

    v% Cat'eter*related interventional procedures

  • 7/18/2019 Cardiovascular Management in Family Medicine

    18/43

    !revention

    &'ere is a range o$ 'ig'ly prevalentcardiovascular diseases and well*known risk $actors) in addition to age)

    se. and genetic $actors) w'ic'inuence an individualscardiovascular risk pro(le% roadly)

    t'ree areas o$ prevention can "edistinguis'ed%

  • 7/18/2019 Cardiovascular Management in Family Medicine

    19/43

    !revention1. Prevention in the total population. Life style

    factors, such as smoking, physical exercise, diet, and

    use o$ alco'ol 'ave impact on t'e cardiovascularrisk%

    2. Prevention in high-risk groups. There is a rangeof chronic clinical conditions that increase t'e risk $orcardiovascular events) w'ic' mainly aect adultsaged :: years or over) suc' as 'ypertension+G39/B mmg) prevalence at least 5:/3patients in t'is age group-% Also) dia"etes+prevalence at least :/3 patients in t'is age

    group- is a condition t'at predisposes $orcardiovascular diseases%3. Prevention after cardiovascular events. Acute

    cardiovascular events such as myocardial in$arctionand stroke) determine mortality and) i$ t'e patient

    survives)

  • 7/18/2019 Cardiovascular Management in Family Medicine

    20/43

    Eective life style and pharmaceuticalinterventions

    Stop smoking A review +5 studies- s'owed t'at smokingcessation interventions in patients wit' coronary 'eart disease

    were associated wit' reduced overall mortality +RRH%;9-+Critc'ley 56-%

    Physical exercise A review +:3 studies- s'owed t'at e.ercise*only re'a"ilitation in patients wit' coronary 'eart disease led to areduction o$ cardiac mortality +RRH%;B- +ollie 5-%

    Diet A review +5? studies- s'owed t'at reduced $at intake led to

    protection $rom C=D events +rate ratio %@9- "ut not $rommortality% &'e degree o$ protection $rom cardiovascular eventsappeared similar in 'ig' and low risk groups) "ut was statisticallysigni(cant only in t'e $ormer +ooper 53-%

    Alcohol 0owered levels o$ alco'ol consumptions were associatedwit' lowered risk o$ C=D events +RRH%;?- +Corrao 5-% +4ote

    t'at t'is was not an intervention study%- Antihypertensive drugs +ACE in'i"itors) calcium antagonists)

    diuretics) "eta*"lockers- A review +5B eJcacy trials- on dierentdrugs s'owed relative risk reductions o$ 3@*55K $or C=D eventsagainst place"o +lood !ressure 0owering etc% 56-%

    Statins A review +:@ studies- s'owed t'at statins wereassociated wit' a reduced relative risk $or ID deat' or non*$atal

  • 7/18/2019 Cardiovascular Management in Family Medicine

    21/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    22/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    23/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    24/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    25/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    26/43

    =ERL I7 RIS,

    Su"#ects wit' any o$ t'e $ollowing

    Documented C=D "y invasive or non*invasive testing +suc'as coronary angiograp'y) nuclear imaging) stressec'ocardiograp'y) carotid plaation +!CI)CA7-) and ot'er arterial revasculari>ation procedures)isc'aemic stroke) perip'eral artery disease +!AD-%

    Dia"etes mellitus +type 3 or type 5- wit' one or more C=risk $actors and/or target organ damage +suc' as

    microal"uminuria 66 mg/59 '-% Severe c'ronic kidney disease +C,D- +7FR )6 m0/min/3%?6

    m5-%

    A calculated SC8RE N3K%

  • 7/18/2019 Cardiovascular Management in Family Medicine

    27/43

    I7 RIS,

    Su"#ects wit' any o$ t'e $ollowing

    Markedly elevated single risk $actors suc' as$amilial dyslipidaemias and severe'ypertension%

    Dia"etes mellitus +type 3 or type 5- "ut wit'outC= risk $actors or target organ damage%

    Moderate c'ronic kidney disease +7FR 6:B

    m0/min/3%?6 m5-% A calculated SC8RE o$ N:K and )3K $or 3*

    year risk o$ $atal C=D%

  • 7/18/2019 Cardiovascular Management in Family Medicine

    28/43

    M8DERA&E RIS,

    Su"#ects are considered to "e at moderate risk w'ent'eir SC8RE is N3 and ):K at 3 years% Many middle*aged su"#ects "elong to t'is category% &'is risk is $urt'er

    modulated "y $actors mentioned a"ove%

    081 RIS,

    &'e low*risk category applies to individuals wit' a SC8RE

    O3K and $ree o$

  • 7/18/2019 Cardiovascular Management in Family Medicine

    29/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    30/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    31/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    32/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    33/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    34/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    35/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    36/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    37/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    38/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    39/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    40/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    41/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    42/43

  • 7/18/2019 Cardiovascular Management in Family Medicine

    43/43

    TERMA!AS"

    mA#$ATe

    c%m &n